Theriva Biologics, Inc. Total Long-Term Debt
Theriva Biologics, Inc. (TOVX) had Total Long-Term Debt of $1.67 million as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:LongTermDebt · last filed 2026-03-12
- 2025-12-31: Long-term Debt $1.67M.
- 2024-12-31: Long-term Debt $92.00K.
- 2023-12-31: Long-term Debt $162.00K.
- 2023-09-30: Long-term Debt $150.00K.
| Period end | Long-term Debt |
|---|---|
| 2025-12-31 | $1.67M 10-K · filed 2026-03-12 |
| 2024-12-31 | $92.00K 10-K · filed 2026-03-12 |
| 2023-12-31 | $162.00K 10-K · filed 2025-03-06 |
| 2023-09-30 | $150.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $153.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $160.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $221.00K 10-K · filed 2024-03-25 |
| 2022-09-30 | $202.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $216.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $229.00K 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |